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Quality of life in chronic venous disease patients
measured by short Chronic Venous Disease
Quality of Life Questionnaire (CIVIQ–14)
in Serbia
Djordje J. Radak, PhD,a Hristina D. Vlajinac, PhD,b Jelena M. Marinkovic´, PhD,c
Miloš Ž. Maksimovic´, PhD,d and Živan V. Maksimovic´, PhD,e Belgrade, Serbia
Background: This was a psychometric validation of the short Chronic Venous Disease Quality of Life Questionnaire
(CIVIQ-14) as quality of life (QOL) instrument for chronic venous disease (CVD) patients.
Methods: Patients aged>18 years who had CVD in CEAP C stages C0s to C6 were included in the study. Diagnosis was made
by general practitioners according to CVD symptoms and visual examination of the lower extremities. QOL was assessed with
the self-administrated CIVIQ-14. The reliability, construct, and convergent validity of the CIVIQ-14 was estimated as well as
QOL of CVD patients according to CEAP C stages.
Results: The study comprised 2260 subjects who fully completed the CIVIQ-14. CIVIQ-14 had a high level of reliability,
construct, and convergent validity, but the structure of its three dimensions (pain [P], physical [PHY], and psychological
[PSY]) was suboptimal. After adjustment for age, body mass index, and number of CVD symptoms, CIVIQ -14 global,
P, PHY, and PSY scores showed significant progressive reduction of QOL from CEAP class C0s to C6. These differences
were present in both sexes. The progressive impairment of the QOL involved primarily the pain and the physical items.
For all CEAP C classes, the P and PHY scores were lower than the PSY scores. Global scores for men and women were:
76.7 and 73.9 for C0s; 75.5 and 70.6 for C1; 67.8 and 64.5 for C2; 68.3 and 61.6 for C3; 60.7 and 54.6 for C4; 49.5 and
50.2 for C5; and 41.3 and 46.7 for C6.
Conclusions: CVD in the lower extremities has a substantial effect on both physical and psychologic aspects of QOL, the
physical aspects of QOL (P and PHY items) being more important. CIVIQ-14 is valuable in assessing QOL in CVD patients.
Further investigations are necessary to confirm the stability of its two dimensions. (J Vasc Surg 2013;58:1006-13.)
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pThe concept of health-related quality of life (QOL) and
its determinants have evolved since the 1980s to include
those aspects of overall QOL that can be clearly shown to
affect health, either physical or mental.1 Several measures
have been used to assess QOL, the Medical Outcomes
Study Short-Form 36 (SF-36) Health Survey being the
most frequently used for patients with various chronic
diseases, including chronic venous disease (CVD).
Because of some specific characteristics of CVD, the
Chronic Venous Disease Quality of Life Questionnaire
(CIVIQ-20) was created and validated in France2 in 1996
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1006s a sensitive instrument to capture the key domains (di-
ensions) of QOL in CVD patients. Psychometric valida-
ion of CIVIQ-20, in France, and internationally, showed
hat the CIVIQ-20 met all of the conditions required for
alidation: relevance, acceptability, reliability, construct va-
idity, and sensibility.3-5
CIVIQ-20 has been extensively used in recent years in
andomized clinical trials to compare the effect of various
ypes of CVD therapy6-18 as well as for discriminative
urpose.19-23 The large use of CIVIQ-20 in different pop-
lations of various countries and in many languages makes
t one of the most often tested instruments on its stability.
revious tests revealed a factorial instability of the social
imension.5 Therefore, Launois et al, the developers of
IVIQ-20, constructed a new stable questionnaire to in-
erpret results from international studies: the CIVIQ-14.
IVIQ-14, a 14-item questionnaire, is a shortened version
f CIVIQ-20. It has been psychometrically validated and its
actorial structure confirmed in Polish, Czech, Spanish, and
rench populations using principal component analysis and
ultitrait/multimethod analysis.24 CIVIQ-14 is a three-
imensional questionnaire including a pain dimension
three items: pain in legs; impairment at work; sleeping
oorly), a physical dimension (five items: climb several
oors; squat/kneel; walk at a good pace; going to parties;
erform athletic activity), and a psychological dimension
six items: feeling nervous; impression of being a burden;
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Volume 58, Number 4 Radak et al 1007embarrassed to show legs; easily becomes irritable; impres-
sion of being disabled; having no desire to go out).
The present investigation is a part of an observational,
multicentric, descriptive survey of CVD under the guidance
of International Union of Phlebology. This is a two-part
study (step 1 and step 2). Step 1 comprised screening of
patients with CVD by general practitioners (GPs) and an
assessment of their QOL by the use of CIVIQ-14. In step
2, follow-up is planned for those patients who, as deter-
mined by the GP, have referral to a venous specialist. The
part of the study presented in this paper had two aims: to
estimate reliability, construct, and convergent validity of
the CIVIQ–14, and to assess QOL in CVD patients.
METHODS
The survey was conducted in Belgrade and Nis, two
major towns in Serbia. It was performed by 78 GPs (15%
of all GPs in these two cities) who participated in continu-
ous education concerning CVD. Continuous education
comprised theoretical and practical education on phlebol-
ogy, the aim of which was to improve their knowledge of
diagnostics and therapy for CVD and CVD definition
according to the CEAP C classification. All men and
women aged18 years consecutively coming to see the GP
for any reason, with the exception of those who came for an
emergency, were asked to participate in the study, fully or
partly (the patient can agree to take part in step 1 but
decline step 2).
For each patient included in the study, the GP com-
pleted a questionnaire (consultation records form) that
collected the following data:
● Demographic characteristics, including age and sex;
● Anthropometric and lifestyle characteristics, including
weight, height, smoking, and physical activity;
● Risk factors for CVD, including family history of ve-
nous leg problems, history of blood clots in veins or
legs, hours spent standing and hours spent sitting per
day, occupation, parity, pregnancy, oral contracep-
tives, and hormonal replacement therapy use;
● Symptoms of CVD, including heavy legs, pain in the
legs, sensation of swelling, sensation of burning, night
cramps, itching, sensation of “pins and needles” in the
legs);
● Current and previous therapy for CVD; and
● The results of clinical examination of the legs.
The CEAP C classification for chronic venous disor-
ders25 was used:
● C0s: no visible or palpable signs of venous disease but
with CVD symptoms
● C1: telangiectases or reticular veins
● C2: varicose veins
● C3: edema
● C4: skin changed—pigmentation, eczema, lipoderma-
tosclerosis, atrophie blanche
● C : healed venous ulcer5
● C6: active venous ulcer tAt the end of the consultation, and only if the GP
udged that patient had CVD, the individual was asked to
omplete a QOL questionnaire. Of 3255 patients evaluated
950 men and 2305 women), 2343 had CVD (72.7%).
iagnosis of CVD in patients who were in CEAP C0s was
ade by the GP after exclusion of other possible causes of
xisting symptoms.
For the QOL assessment, the CVD-specific, self-
dministered CIVIQ-14 with 14 equally weighed items was
sed. CIVIQ-14 was translated into Serbian by medical
xperts. The recall period was the previous 4 weeks. Replies
ere graded on a 5-point Likert scale.
Three scores were calculated: a score per item (range,
-5), a score per dimension (range, 0-100), and a global
core (range, 0-100). The score for each dimension was
btained by adding scores for each constituent item, and
he global index was obtained by summing scores for the 14
tems. Absolute scores were converted into an index follow-
ng the authors’ instructions.2 To facilitate the interpreta-
ion of the results, the scores presented in this report were
inearly transformed into a scale of 0 to 100, with the
ighest score indicating the best QOL.
Statistical analysis. Face validity (acceptability) of the
IVIQ-14 was described in terms of quality of completion
n an item and overall. For the assessment of construct
alidity of the Serbian version of CIVIQ-14, as well as its
tructure, exploratory factor analysis with principal axis
actoring (PAF) as the extraction method and Varimax as
he rotation method was used.4 Construct validity of the
uestionnaire was also analyzed by item-convergent and
tem-discriminant validity. Item-convergent validity was
ccepted when items were significantly correlated with their
wn dimension (Pearson correlation coefficients 0.40),
nd item-discriminant validity was accepted when items
ere more strongly correlated with their own dimension
han with the other dimensions.
Cross-sectional (ie, clinical) validity was assessed by
pearman correlation coefficients between clinical status
easured by CEAP/number of symptoms and QOL
cores. Internal consistency reliability was validated using
he Cronbach  coefficient. The maximum value of the
oefficient is 1 and the minimum recommended value to
nsure acceptable reliability is 0.7.26 Study participants’
haracteristics in different CEAP C class of CVD were
ompared using the 2 test and analysis of variance.
Univariate and multivariate linear regression analyses
ith the enter method were performed to assess the rela-
ionships among sociodemographic and clinical parameters
nd QOL. Collinearity was assessed by variance inflation
actor. Analysis of covariance was used to adjust CIVIQ-14
cores for age, body mass index (BMI), and number of
ymptoms. All P values are based on two-tailed tests, and
 .05 was considered significant. Data were analyzed
sing SPSS 19 software (SPSS Inc, Chicago, Ill).
ESULTS
Study population. The GPs determined 2343 pa-
ients had CVD, and the study included 2260 who fully
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October 20131008 Radak et alcompleted the CIVIQ-14. Characteristics of the study pop-
ulation are presented in Table I. Women significantly out-
numbered men in the whole study group and in CEAP C
groups (P .001), the difference being less pronounced in
higher C classes, especially in C4 to C6. Patients in CEAP C
groups significantly differed in mean age (P .001), mean
BMI (P  .001), and mean number of CVD symptoms
(P  .001). Age, BMI, and number of CVD symptoms
almost gradually increased with increasing CEAP C class.
Multiple comparisons showed significant differences be-
tween all CEAP C classes, with the exception of the follow-
ing: for sex—between C0s, C2, C3, C4, C5, and C6; for
age—between C2 and C3, as well as C4, C5, and C6; for
BMI—between C0s, C1, and C2, as well as C3, C4, C5, and
C6; for number of symptoms—between C0s and C1, as well
as between C4, C5, and C6.
Psychometric validation of the Serbian CIVIQ-14.
The 2343 patients who the GPs had determined had
CVD agreed to complete the CIVIQ-14. The acceptabil-
ity of the CIVIQ-14 questionnaire was evaluated from
the response rates to each of the questions asked (range
from 99.1% for “trouble at work” to 98.4% for “I do not
feel like going out”) and by the number of question-
naires completed (96.5%).
The subsequent analyses included 2260 patients who
fully completed the CIVIQ-14. Exploratory factor analysis
confirmed the existence of three dimensions in CIVIQ-14,
with the slight instability in question 4 (climb several floors)
(Table II). According to the analysis, 14 questions were
clustered in three dimensions: pain dimension (P), physical
dimension (PHY), and psychological dimension (PSY).
For each item (question), three correlation coefficients
were calculated. The first assessed the correlation between
an item and the dimension to which it belonged, and the
second and third assessed the correlation with the other
two dimensions. If the first correlation was  0.40, the
Table I. Characteristics of study population
Variable C0s C1 C2
Patients, No. 187 555 754
No. (%) No. (%) No. (%) N
Sex
Men 49 (26.2) 102 (18.4) 214 (28.4) 110
Women 138 (73.8) 453 (81.6) 540 (71.6) 254
Mean (SD) Mean (SD) Mean (SD) M
Age,a years 51.6 (12.8) 54.0 (12.9) 58.2 (12.7) 5
BMI, kg/m2 26.0 (4.1) 26.4 (4.3) 26.6 (3.8) 2
Symptoms, No.a 3.1 (1.4) 3.3 (1.5) 3.9 (1.5)
BMI, Body mass index; SD, standard deviation.
aP  .001 for differences between all CEAP C classes (C0s to C6).convergent validity was considered to be good. If the first Correlation was greater than the second and third, the item
atched its dimension and its discriminating validity was
ood. CIVIQ items were significantly correlated with their
wn dimension. Pearson correlation coefficients were:
.564-0.831 for P; 0.520-0.880 for PHY; and 0.631-
.847 for PSY. Its items were more strongly correlated with
heir own dimension (Pearson correlation coefficients were
.564-0.880) than with the other dimensions (Pearson
orrelation coefficients were 0.148-0.616).
The Spearman correlation coefficient was0.473 (P
001) between clinical status measured by CEAP and global
IVIQ-14 score, and 0.460 (P  .001) between the
umber of symptoms and global CIVIQ-14. The corre-
ponding values of the Spearman correlation coefficient
ere: 0.388 (P  .001) and 0.485 (P  .001) for P;
0.441 (P  .001) and 0.386 (P  .001) for PHY; and
0.415 (P  .001) and 0.403 (P  .001) for the PSY.
The internal consistency reliability was measured by
ronbach  coefficients. The Cronbach  was 0.934 for
IVIQ-14, 0.783 for P, 0.908 for PHY, and 0.888 for
SY. Moreover, the percentages of patients having the
owest (floor effect) or highest (ceiling effect) possible
cores were low (floor effect: 0.1%-0.2%; ceiling effect:
.7%-12.0%), indicating that most problems dealing with
he disease were covered by the questionnaire.
QOL in CVD patients assessed by CIVIQ-14.
ccording to multivariate linear regression analysis, QOL
n patients with CVD (global, P, PHY, and PSY scores) was
ignificantly (P  .001) related to all observed variables:
EAP C class, number of symptoms, age, sex, and BMI
Table III). QOL scores were lower in women than in men,
nd the increase of CEAP C class, the increase of age, BMI,
nd number of symptoms was related to the decrease of
OL scores. The only exception was age, which had no
ignificant effect on PSY score (P  .333).
CIVIQ-14 global, P, PHY, and PSY scores, assessed by
CEAP C
C3 C4 C5 C6 Total
364 299 78 23 2260
) No. (%) No. (%) No. (%) No. (%)
.0) 104 (34.8) 33 (42.3) 9 (39.1) 621 (27.5)
.8) 195 (65.2) 45 (57.7) 14 (60.9) 1639 (72.5)
(SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
12.1) 62.6 (11.0) 61.4 (13.9) 63.8 (12.9) 57.4 (12.9)
4.3) 28.1 (4.3) 28.3 (4.1) 28.7 (5.4) 27.0 (4.2)
1.4) 4.8 (1.6) 5.2 (1.6) 5.2 (1.5) 3.9 (1.6)o. (%
(30
(69
ean
8.0 (
8.1 (
4.3 (EAP C classes, are presented in Table IV for all partici-
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Volume 58, Number 4 Radak et al 1009Table II. Exploratory factor analysis (n  2260 patients)
Principal axis factoring with Promax rotationa
Factors loadings by componentb
Psychologic Physical Pain
Pain components
Pain in legs .230 .220 .711
Impairment at work .329 .279 .673
Sleeping poorly .347 .227 .482
Physical components
Climb several floors .271 .469 .589
Squat/kneel .264 .557 .551
Walk at a good pace .242 .675 .458
Going to parties .293 .793 .258
Perform athletic activity .269 .795 .231
Psychologic components
Feeling nervous .570 .244 .468
Impression of being a burden .695 .243 .322
Embarrassed to show legs .604 .134 .197
Easily becomes irritable .713 .199 .317
Impression of being disabled .766 .206 .190
Having no desire to go out .690 .365 .162
aKaiser-Meyer-Olkin measure of sampling adequacy  0.94; % of variance explained  63.27.
bThe factor loadings are the correlation coefficients between the variables (rows) and factors (columns).Table III. Univariate and multivariate linear regression analysisa
Variable
Univariate Multivariate
b-coefficient 95% CI P b-coefficient 95% CI P VIF
Global score
Sex 2.26 4.16 to 0.36 .020 4.20 5.75 to 2.65 .001 1.030
Age 0.44 0.51 to 0.38 .001 0.23 0.29 to 0.18 .001 1.102
BMI 1.18 1.38 to 0.99 .001 0.49 0.66 to 0.33 .001 1.081
CVD symptoms, No. 6.04 6.51 to 5.57 .001 3.99 4.46 to 3.53 .001 1.188
CEAP C class 7.30 7.87 to 6.73 .001 4.87 5.45 to 4.30 .001 1.228
P score
Sex 1.71 3.53 to 0.10 .065 2.72 4.25 to 1.18 .001 1.030
Age 0.31 0.37 to 0.25 .001 0.14 0.19 to 0.09 .001 1.102
BMI 0.85 1.04 to 0.66 .001 0.26 0.43 to 0.09 .002 1.081
CVD symptoms, No. 6.06 6.50 to 5.62 .001 4.74 5.20 to 4.27 .001 1.188
CEAP C class 5.79 6.37 to 5.22 .001 3.37 3.94 to 2.79 .001 1.228
PHY score
Sex 1.01 3.52 to 1.50 .430 4.25 6.33 to 2.18 .001 1.030
Age 0.79 0.87 to 0.71 .001 0.54 0.62 to 0.47 .001 1.102
BMI 1.69 1.94 to 1.43 .001 0.76 0.99 to 0.53 .001 1.081
CVD symptoms, No. 6.67 7.30 to 6.01 .001 3.81 4.43 to 3.19 .001 1.188
CEAP C class 9.05 9.82 to 8.28 .001 5.85 6.62 to 5.08 .001 1.228
PSY score
Sex 3.58 5.60 to 1.56 .001 4.90 6.69 to 3.12 .001 1.030
Age 0.22 0.29 to 0.15 .001 0.03 0.09 to 0.03 .333 1.102
BMI 0.93 1.14 to 0.72 .001 0.40 0.59 to 0.20 .001 1.081
CVD symptoms, No. 5.51 6.03 to 5.00 .001 3.78 4.31 to 3.24 .001 1.188
CEAP C class 6.60 7.23 to 5.96 .001 4.82 5.49 to 4.15 .001 1.228
BMI, Body mass index; CI, confidence interval; CVD, chronic venous disease; P, pain components; PHY, physical components; PSY, psychologic components;
VIF, variance inflation factor.
aThe association of each characteristic with the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-14) global, physical, and psychologic scores.
Sex codes are: 1-men and 2-women.
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October 20131010 Radak et alpants and separately for men and for women. The global, P,
and PHY scores were adjusted for age, BMI, and number of
CVD symptoms, and the PSY score was adjusted for BMI
and number of CVD symptoms. Scale scores were signifi-
cantly correlated (P  .001). Spearman rank correlation
coefficient between P and PHY scores was 0.680, between
P and PSY scores was 0.638, and between PHY and PSY
scores was 0.649.
All scores showed progressive reduction of QOL from
CEAP C0s to C6 (P  .001). Global scores 70 were
present in both sexes from CEAP C2. Greater impairment
of QOL was reported by patients in CEAP C4 to C6.
Compared with men, women had lower global scores in C0
to C4 and higher in C5 and C6. P and PHY scores 60.0
were present in both men and women from CEAP C2 and
onward, with the exception of P score in men with CVD
CEAP C3. PSY scores were higher in both sexes than those
for P and PHY scores, and PSY scores 60.0 were present
only in CEAP C5 and C6. P, PHY, and PSY scores were
lower in women, with the exception of P and PHY scores
for C5 and C6 and the PSY score for C5, which were lower
in men.
DISCUSSION
The results of the present study suggest that CIVIQ-14
is a valuable measure of QOL of patients with CVD. The
results also show that patients with CVD have significant
impairment of QOL.
The most commonly used disease-specific QOL instru-
ments for CVD are the Aberdeen Varicose Vein Question-
naire (AAQ),27 and CIVIQ-20, and the most frequently
used generic QOL instrument for CVD is the SF-36. The
Table IV. Summary of Chronic Venous Disease Quality o
class
CIVIQ-14 score C0s C1 C2
Men, No. 49 102 214
Globala 76.7 (16.5) 75.5 (16.6) 67.8 (16.5
Pa 69.4 (17.2) 64.6 (16.8) 58.8 (16.5
PHYa 73.2 (23.6) 71.5 (23.1) 58.8 (22.6
PSYb 84.2 (19.1) 84.7 (19.2) 79.4 (19.0
Women, No. 138 453 540
Globala 73.9 (16.7) 70.6 (16.8) 64.5 (16.4
Pa 65.2 (16.7) 60.4 (16.8) 56.4 (16.4
PHYa 68.1 (22.4) 64.4 (22.6) 57.7 (22.0
PSYb 83.3 (19.1) 80.9 (19.3) 74.6 (19.0
Total, No. 187 555 754
Globala 74.7 (17.0) 71.5 (17.0) 65.4 (16.6
Pa 66.3 (16.9) 61.2 (16.9) 57.0 (16.5
PHYa 69.3 (22.0) 65.7 (22.8) 57.8 (22.3
PSYb 83.3 (19.7) 81.5 (19.7) 76.0 (19.2
BMI, Body mass index; P, pain components score; PHY, physical compone
aAdjusted for age, BMI, and number of chronic venous disease symptoms.
bAdjusted for body mass index and number of chronic venous disease sympCIVIQ-14 was derived from the CIVIQ-20. As already otated, CIVIQ-20 is a feasible, valid, reliable, and respon-
ive tool in the assessment of QOL in patients with CVD.2
owever, use of the global CIVIQ-20 score rather than
cores for each dimension was recommended because of
nstability of some dimensions, especially social.2 To im-
rove the questionnaire, a shortened form of the instru-
ent, CIVIQ-14, was made by exclusion of unstable items
rom CIVIQ-20; that is, items that belonged to more than
ne domain (dimension).5,24 In addition, the acceptability
f a questionnaire is always better when it is short; conse-
uently, the use of a short questionnaire is preferable if it
urns out to be valid.
The analyses that could be performed with our data
howed that CIVIQ-14 had a high level of reliability,
onstruct, and convergent validity; that is, it provided good
iscrimination between the clinical CEAP classes. It also
as acceptable to patients and easy to complete. These
haracteristics of CIVIQ-14 make it valuable in assessing
OL in CVD patients. According to the analysis of data
rom Serbia, the structure of three dimensions of
IVIQ-14 was suboptimal. One item in one of the analysis
lipped from one dimension to another, but it could be
aused by inadequate translation of questions to Serbian. In
he present study, CIVIQ-14 was not compared with the
AQ or the SF-36. In future investigations, it would be
esirable to use various QOL instruments in the same
roup of patients to see their advantages and disadvantages
nd to assess whether it is sufficient to use only one, and if
o, which one. Both et al28 recommended using a generic
OL instrument, such as the SF-36, with CIVIQ or AAQ
ecause the latter two are more specific for the assessment
e Questionnaire (CIVIQ-14) scores by sex and CEAP C
C class, mean (SD)
C3 C4 C5 C6
110 104 33 9
68.3 (16.5) 60.7 (16.6) 49.5 (16.5) 41.3 (16.5)
60.7 (16.6) 53.2 (16.9) 44.9 (16.8) 36.9 (16.4)
57.5 (22.8) 49.6 (23.2) 39.3 (23.1) 23.8 (22.6)
79.9 (19.0) 71.5 (19.1) 57.5 (19.1) 55.8 (19.0)
254 195 45 14
61.6 (16.5) 54.6 (16.9) 50.2 (16.6) 46.7 (16.5)
55.6 (16.5) 51.7 (16.9) 48.7 (16.5) 42.3 (16.4)
53.4 (22.1) 46.3 (22.8) 41.7 (22.2) 41.9 (22.1)
71.9 (19.1) 63.7 (19.4) 59.1 (19.2) 53.9 (19.1)
364 299 78 23
63.7 (16.7) 56.8 (17.1) 50.0 (16.8) 44.6 (16.6)
57.2 (16.5) 52.3 (16.9) 47.5 (16.6) 40.5 (16.5)
54.7 (22.4) 47.6 (22.9) 41.2 (22.5) 34.9 (22.3)
74.4 (19.3) 66.6 (19.8) 58.6 (19.4) 54.9 (19.2)
re; PSY, psychologic components score; SD, standard deviation.f Lif
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Volume 58, Number 4 Radak et al 1011In the present study, all of the CIVIQ-14 scores—
global, P, PHY, and PSY—showed progressive reduction of
QOL from CEAP C0s to C6. Global scores for CEAP
classes C0s to C4 (76.7-60.7 in men and 74.0-54.6 in
women) were similar to the CIVIQ-20 scores in the Reflux
Assessment and Quality of Life Improvement with Micron-
ized Flavonoids (RELIEF) study, a prospective, multi-
center, international study from 18 countries.5 The study
included 3956 patients and assessed QOL in CVD patients
(with and without venous reflux) treated with flavonoid
fractions (70.1-57.9 for both sexes taken together).4 In a
small study in Italy,29 the global CIVIQ score ranged from
85.8 in CEAP C1 to 57.9 in CEAP C4, and it was 41.0 in
CEAP C5 to C6. Decreasing QOL in participants with
higher CEAP classes was also present in the McLafferty et
al30 study, which used only 11 questions (pain, physical,
and social items) of the CIVIQ-20.
The progressive impairment of the QOL in the present
study involved primarily the P and PHY items. For all
CEAP C classes, the P and PHY scores were lower than the
PSY scores. P and PHY scores 60 were already present in
C2 patients, and the same psychologic impairment of QOL
was present only in patients in advanced stages of disease
(healed or active skin ulcer). These results cannot be com-
pletely compared with the results obtained by CIVIQ-20,
but in the RELIEF study, scores for the psychologic dimen-
sion were also higher than scores for pain and physical
dimensions. The difference was less pronounced compared
with the social dimension.5
The results obtained can also be compared with the
results of QOL assessed by the use of the SF-36, because
some studies found close correlation among CIVIQ-20
and the SF-36 and SF-12.29,31
In the Italian study, the physical items of SF-36 also had
greater impact on QOL than mental items.29 Results from
the San Diego study,32 which used the SF-36, suggested
that CVD affected the functional scales but did not seem to
affect the well-being aspects. Kurz et al33 found significant
gradations in SF-36 physical component scores by disease
severity, but found few differences for mental component
scores. These results were contradicted by the QOL study
in CVD patients from Belgrade,34 assessed by SF-36, that
showed significant reduction of both physical functioning
and mental health. These differences could be explained by
cultural, ethnic, and environmental differences between the
observed populations.29
Authors of all mentioned studies, including the present
one, consider that the greater importance of the functional
aspects of QOL in CVD patients than the psychologic
aspects suggests that CVD could not be considered as an
esthetic problem, but as a disease.
As in the RELIEF study,5 QOL in the present survey
was lower in older patients and in women. Age had a highly
significant effect on global scores and P and PHY scores but
not on PSY scores. It could be expected and it is under-
standable that the emotional effect of CVD is greater in
younger than in older persons, especially in women. In the
Kurz et al33 study, QOL in women, particularly SF-36 Oental component scores, was lower. Lower scores in
omen were also observed in other QOL studies in cardiac
ehabilitation patients and in persons with rheumatoid
rthritis.35,36
Inverse findings for C5 and C6 classes in the present
tudy could be explained by the small number of patients
especially men) in these CEAP C classes. According to the
esults of the present study, CVD symptoms were signifi-
antly associated with QOL scores independently of age,
ex, BMI, and CEAP C class. An independent association of
VD symptoms with QOL was present in the RELIEF
tudy,5 and the negative prognosis regarding QOL associ-
ted with the severity of the symptoms at baseline was also
ound. Increased BMI, which has been related to CVD in a
umber of studies,37-39 also was significantly related to
OL in CVD patients in the present investigation, inde-
endently of age, sex, number of CVD symptoms, and
EAP C class. A population study conducted in Belgrade40
howed that increased BMI and obesity, in particular, were
dversely associated with QOL measured by the SF-36.
hat association was much greater on physical than mental
ealth, regardless of the participant’s sex.
The present study has several limitations: Test–retest
eproducibility and responsiveness of CIVIQ-14 were not
ssessed, diagnosis of CVD was made by a GP and not
onfirmed by a specialist, and diagnosis of CVD was made
n the basis of symptoms, clinical, and visible changes, and
ot on the functional basis. Kaplan et al32 found that the
isual categories explained most of the variance in SF-36
hysical component scores, and that in the mental compo-
ent scores model, differences between both the visual and
ltrasound categories were nonsignificant. Therapy re-
eived by some patients was not accounted for in the
nalysis, but the effect of therapy was the most probably
olved by adjusting CIVIQ-14 scores on CVD symptoms.
he Serbian version of CIVIQ-14 was simply translated
rom the English without transcultural validation of it.
ONCLUSIONS
CVD in the lower extremities has a substantial effect on
uality of life. CIVIQ-14 had a high level of reliability and
alidity. Further investigations are necessary to confirm the
tability of its three dimensions.
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